BridgeMD
New treatment option for Posterior Malleolus Fractures
Official title Weber B Ankle Fractures With Associated Posterior Malleolus Fracture
ClinicalTrials.gov ID: NCT05413707
What this study is testing
- What it's testing
- Ankle fractures constitute 9% of all fractures and have an incidence of approximately 187 per 100,000 persons per year in Norway. A posterior malleolar fragment (PMF), located on the lower backside of the tibia, is present in up to 46% of Weber B.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Posterior malleolar (PM) fracture, of Mason \& Molly type 2A/2B, associated with Weber B lateral malleolar fracture, with or without medial malleolar...
- Posterior malleoli \>=2 mm displaced (on CT in axial, sagital or coronal plane)
- Patients informed, written consent
- Age 18-65 years
- For inclusion axial CT images are examined
You likely can't join if
- Non-compliant patient, i.e.: dementia, alcohol- or substance abuse
- ASA-4 patients
- Known congenital bone decease
- Pathological fractures
- Immunocompromised patients
- Tourists or patients on a short-term work/study permit
See the full eligibility criteria
- Posterior malleolar (PM) fracture, of Mason \& Molly type 2A/2B, associated with Weber B lateral malleolar fracture, with or without medial malleolar fracture
- Posterior malleoli \>=2 mm displaced (on CT in axial, sagital or coronal plane)
- Patients informed, written consent
- Age 18-65 years
- For inclusion axial CT images are examined
- Measurements are performed 5 millimeters (mm) cranial to the tibia plafond
- Posterior malleolus fractures involving less than 40% of the fibular notch are included.
- Non-compliant patient, i.e.: dementia, alcohol- or substance abuse
- ASA-4 patients
- Known congenital bone decease
- Pathological fractures
- Immunocompromised patients
- Tourists or patients on a short-term work/study permit
- Previous injury or condition of the ipsilateral ankle or ipsilateral lower extremity with a resulting dysfunction
- Poor controlled diabetes
- Patients with known arterial insufficiency
- Open fractures
- Severely traumatized patients (ISS\>16)
- Patient declines to participate in study
The study team makes the final eligibility decision.
Where it's taking place
- Bergen, Vestland, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergen, Vestland, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.